COVID-19

Good News | Cross-Reactive T-Cells Immunity | Oxford Vaccine Put on Hold || Dr Junaid Asghar

Memory T cells induced by previous pathogens can shape susceptibility to, and the clinical severity of, subsequent infections, such as Covid .

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK.

#LongTermImmunityInCovid
#OxfordVaccinePaused